Recombinant TNFRSF12A (Enavatuzumab Biosimilar) antibody
Quick Overview for Recombinant TNFRSF12A (Enavatuzumab Biosimilar) antibody (ABIN7597658)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Enavatuzumab Biosimilar Antibody
-
Specificity
- FGF-inducible 14, TNFRSF12A, FN14, CD266, TweakR, Fibroblast growth factor-inducible immediate-early response protein 14, Tweak-receptor, Tumor necrosis factor receptor superfamily member 12A
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 3.33 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- TNFRSF12A (Enavatuzumab Biosimilar)
-
Alternative Name
- Enavatuzumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- FGF-inducible 14, TNFRSF12A, FN14, CD266, TweakR, Fibroblast growth factor-inducible immediate-early response protein 14, Tweak-receptor, Tumor necrosis factor receptor superfamily member 12A
-
UniProt
- Q9NP84
-
CAS-No
- 1062149-33-0
Target
-